Godelieve is a 77-year-old retired teacher. One year ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic examination for painless haematuria. The pathology report indicated pTa grade 2,...
Improving detection of high-grade recurrences missed by WLC using a urinary biomarker Reviewed by Marek Babjuk Surveillance for non-muscle-invasive bladder cancer (NMIBC) relies on routine white-light cystoscopy (WLC) and urinary cytology as the diagnostic...
Peter, a 72-year-old retired engineer, was diagnosed with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC) 18 months ago. Following a successful transurethral resection of the bladder tumour (TURBT) and re-TURBT without further pathology, he received a...
The DaBlaCa-15 trial paves the way for urinary biomarker integration Reviewed by Joost Boormans Non-muscle-invasive bladder cancer (NMIBC) demands diligent and often lifelong surveillance, primarily through frequent cystoscopies. While crucial for detecting...
Consider the same patient, but now with the following changes (marked in yellow): Henry, a 70-year-old former creative director in a chocolate company, was initially diagnosed with a solitary small Ta low-grade (LG) tumour. He received 1 immediate chemotherapy...
Henry, a 70-year-old former creative director in a chocolate company, was initially diagnosed with a solitary small Ta low-grade (LG) tumour. He received 1 immediate chemotherapy instillation during transurethral resection of the bladder tumour (TURBT). Follow-up...
Key perspectives from the EAU guidelines panel Reviewed by Paolo Gontero The current standard-of-care for NMIBC surveillance The 2025 EAU guidelines recommend cystoscopy as standard-of-care for the surveillance of all patients with non-muscle-invasive bladder...
Reviewed by Marek Babjuk and Paolo Gontero The 2024 EAU guidelines mention a study concluding that FISH and Bladder EpiCheck® along with cytology could be helpful as an ancillary tool in the diagnosis of upper tract urothelial carcinoma (UTUC) [1]. The...
Improvements in the initial diagnostic workup for bladder cancer Did you know that you can decrease your patient’s burden and discomfort during the initial workup for bladder cancer with the implementation of urinary biomarkers? According to the 2024 EAU...
Watch the interviews with expert urologists Dr. Félix Guerrero-Ramos and Prof. Dr. Fred Witjes sharing their clinical experiences about alternating cystoscopies with urinary biomarkers in the follow-up schedule of patients with non-muscle-invasive bladder cancer...
